The global Drug Discovery Informatics market is expected to grow upto US$ 5.15 Billion by 2028, at CAGR of about 9.85% during the forecast period.
Drug Discovery Informatics aids the users to address large volume of data storage & management and processing & analyzing the gained results. These drug discovery informatics platforms operate bioinformatics algorithms for processing life science data and uses various in silico models for analyzing the data gained. Identification of lead molecules necessitates synthesis and analysis of many derivatives which can be equipped with the support of in silico modeling tools. Success of a drug discovery experiment be contingent extensively on effectiveness of tools employed to assess varied aspects of drugs. In silico tools used herein contain modeling tools for resolve of 3D structures of ligand and protein-ADMET assessment-affinity assessment in docking and drug-ligand interaction for pharmacological profiling. Major market participants are complicated in adoption of in silico modeling tools, which is anticipated to work in favor of the market. In silico tools are promising tools that offer valuable structural screening and information validation at a fraction of the cost of traditional methods, shortening the discovery process to a great extent.
The global Drug Discovery Informatics market is segregated on the basis of Application as Drug Development and Drug Discovery. Based on Solution the global Drug Discovery Informatics market is segmented in Services and Software. Based on End User the global Drug Discovery Informatics market is segmented in Biotechnology Companies, Contract Research Organization, Pharmaceutical Companies, and Other End Users.
Based on Function, the global Drug Discovery Informatics market is segmented in Molecular Modelling, Library & Database Preparation, Other functions, Sequencing and Target Data Analysis, and Docking.
The global Drug Discovery Informatics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Drug Discovery Informatics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Infosys Ltd, GVK Biosciences Private Limited, Albany Molecular Research Inc, ChemBridge Corporation, Charles River Laboratories International, Inc, Selvita, Jubilant Life Sciences Limited, Collaborative Drug Discovery Inc., NOVO INFORMATICS PVT. LTD, Certara, L.P., and others are among the major players in the global Drug Discovery Informatics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Drug Discovery Informatics Market has been segmented as below:
Drug Discovery Informatics Market, By Application
Drug Discovery Informatics Market, By Solution
Drug Discovery Informatics Market, By End User
Drug Discovery Informatics Market, By Function
Drug Discovery Informatics Market, By Region
Drug Discovery Informatics Market, By Company
The report covers:
Report Scope:
The global Drug Discovery Informatics market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Drug Discovery Informatics market share. Major industry players with significant revenue share include Infosys Ltd, GVK Biosciences Private Limited, Albany Molecular Research Inc, ChemBridge Corporation, Charles River Laboratories International, Inc, Selvita, Jubilant Life Sciences Limited, Collaborative Drug Discovery Inc., NOVO INFORMATICS PVT. LTD, Certara, L.P., and others.
Reasons to Buy this Report:
Some of the recent developments in Drug Discovery Informatics Market are as follows:
PerkinElmer, Inc
Thermo Fisher Scientific, Inc
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Connected Drug Delivery Devices Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Drug Discovery Informatics Market, By Application
5.1 Introduction
5.2 Drug Development
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Drug Discovery
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6. Drug Discovery Informatics Market, By Solution
6.1 Introduction
6.2 Services
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Software
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Drug Discovery Informatics Market, By End User
7.1 Introduction
7.2 Biotechnology Companies
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Contract Research Organization
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Pharmaceutical Companies
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Other End Users
7.5.1 Market Overview
7.5.2 Market Size and Forecast
8. Drug Discovery Informatics Market, By Function
8.1 Introduction
8.2 Molecular Modelling
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Library & Database Preparation
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Other functions
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Sequencing and Target Data Analysis
8.5.1 Market Overview
8.5.2 Market Size and Forecast
8.6 Docking
8.6.1 Market Overview
8.6.2 Market Size and Forecast
9. Drug Discovery Informatics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Drug Discovery Informatics, By Application
9.2.2 North America Drug Discovery Informatics, By Solution
9.2.3 North America Drug Discovery Informatics, By End User
9.2.4 North America Drug Discovery Informatics, By Function
9.3 Europe
9.3.1 Europe Drug Discovery Informatics, By Application
9.3.2 Europe Drug Discovery Informatics, By Solution
9.3.3 Europe Drug Discovery Informatics, By End User
9.3.4 Europe Drug Discovery Informatics, By Function
9.4 Asia-Pacific
9.4.1 Asia-Pacific Drug Discovery Informatics, By Application
9.4.2 Asia-Pacific Drug Discovery Informatics, By Solution
9.4.3 Asia-Pacific Drug Discovery Informatics, By End User
9.4.4 Asia-Pacific Drug Discovery Informatics, By Function
9.5 Rest of the World
9.5.1 Rest of the World Drug Discovery Informatics, By Application
9.5.2 Rest of the World Drug Discovery Informatics, By Solution
9.5.3 Rest of the World Drug Discovery Informatics, By End User
9.5.4 Rest of the World Drug Discovery Informatics, By Function
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
11.1 Infosys Ltd
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 GVK Biosciences Private Limited,
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Albany Molecular Research Inc
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 ChemBridge Corporation
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Charles River Laboratories International, Inc
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Selvita
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Jubilant Life Sciences Limited
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 Collaborative Drug Discovery Inc.
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 NOVO INFORMATICS PVT. LTD
11.9.1 Company Overview
11.9.2 Product/Service Landscape
11.9.3 Financial Overview
11.9.4 Recent Developments
11.10 Certara, L.P.
11.10.1 Company Overview
11.10.2 Product/Service Landscape
11.10.3 Financial Overview
11.10.4 Recent Developments
11.11 PerkinElmer, Inc
11.11.1 Company Overview
11.11.2 Product/Service Landscape
11.11.3 Financial Overview
11.11.4 Recent Developments
11.12 Thermo Fisher Scientific, Inc
11.12.1 Company Overview
11.12.2 Product/Service Landscape
11.12.3 Financial Overview
11.12.4 Recent Developments
The Drug Discovery Informatics Market has been segmented as below:
Drug Discovery Informatics Market, By Application
Drug Discovery Informatics Market, By Solution
Drug Discovery Informatics Market, By End User
Drug Discovery Informatics Market, By Function
Drug Discovery Informatics Market, By Region
Drug Discovery Informatics Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
